Epigallocatechin-3-Gallate Protects Na+ Channels in Rat Ventricular Myocytes Against Sulfite

被引:8
作者
Wei, Haiying [2 ]
Meng, Ziqiang [1 ]
机构
[1] Shanxi Univ, Inst Environm Med & Toxicol, Taiyuan 030006, Peoples R China
[2] Shanxi Univ, Coll Environm Sci & Resources, Taiyuan, Peoples R China
关键词
Epigallocatechin-3-gallate; Antioxidant; Sulfite; Na+ channel; Ventricular myocyte; POLLUTANT SODIUM-SULFITE; GREEN TEA; ANTIOXIDANT ENZYMES; HUMAN NEUTROPHILS; ACTIVATION; MECHANISMS; ATHEROSCLEROSIS; ANGIOGENESIS; POLYPHENOLS; OXIDATION;
D O I
10.1007/s12012-010-9075-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sulfite (bisulfite/sulfite) can affect voltage-gated sodium (Na+) channels (VGSC) in a concentration-dependent manner in isolated rat ventricular myocytes. In this study, the effect of epigallocatechin-3-gallate (EGCG) on VGSC in isolated ventricular myocytes was studied. Ventricular myocytes were exposed to 10 mu M bisulfite/sulfite for 10 min, and EGCG was then administered in different concentrations (10, 30, 50 mu g ml(-1)). Decreased activity of superoxide dismutase, catalase (CAT) and glutathione peroxidase (GPx) was observed after bisulfite/sulfite exposure, with significant increase in Na+ currents (I (Na)) and alterations in half-activation voltage and half-inactivation voltage. Intracellular reactive oxygen species (ROS) such as hydrogen peroxide (H2O2), hydroxyl (OH center dot), and superoxide anion (O (2) (center dot-) ) were increased. After EGCG treatment, activity of the aforementioned enzymes increased while the ROS level decreased. The effects progressed with increasing amounts of EGCG, up to a level similar to blank control at the dose of 50 mu g ml(-1) EGCG, EGCG also reduced the I (Na) and reversed the alterations in half-activation voltage and half-inactivation voltage. In conclusion, EGCG could protect Na+ channels in rat ventricular myocytes against the oxidative damage induced by sulfite as a scavenger of the ROS.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 27 条
  • [11] Effect of green tea on angiogenesis and severity of atherosclerosis in cholesterol-fed rabbit
    Kavantzas, N.
    Chatziioannou, A.
    Yanni, A. E.
    Tsakayannis, D.
    Balafoutas, D.
    Agrogiannis, G.
    Perrea, D.
    [J]. VASCULAR PHARMACOLOGY, 2006, 44 (06) : 461 - 463
  • [12] Variable pulmonary responses from exposure to concentrated ambient air particles in a rat model of bronchitis
    Kodavanti, UP
    Mebane, R
    Ledbetter, A
    Krantz, T
    McGee, J
    Jackson, MC
    Walsh, L
    Hilliard, H
    Chen, BY
    Richards, J
    Costa, DL
    [J]. TOXICOLOGICAL SCIENCES, 2000, 54 (02) : 441 - 451
  • [13] Pharmacological effects of green tea on the gastrointestinal system
    Koo, MWL
    Cho, CH
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 500 (1-3) : 177 - 185
  • [14] Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology
    Matés, JM
    [J]. TOXICOLOGY, 2000, 153 (1-3) : 83 - 104
  • [15] MUTATA N, 2009, CELL IMMUNOL, V259, P21
  • [16] Final report on the safety assessment of Sodium Sulfite, Potassium Sulfite, Ammonium Sulfite, Sodium Bisulfite, Ammonium Bisulfite, Sodium Metabisulfite and Potassium Metabisulfite
    Nair, B
    Elmore, AR
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2003, 22 : 63 - 88
  • [17] Study of the interaction of sulfur dioxide derivative with cardiac sodium channel
    Nie, AF
    Meng, ZQ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2005, 1718 (1-2): : 67 - 73
  • [18] Activation of human neutrophils by the air pollutant sodium sulfite (Na2SO3):: Comparison with immature promyelocytic HL-60 and DMSO-differentiated HL-60 cells reveals that Na2SO3 is a neutrophil but not a HL-60 cell agonist
    Pelletier, M
    Savoie, A
    Girard, D
    [J]. CLINICAL IMMUNOLOGY, 2000, 96 (02) : 131 - 139
  • [19] Rao MVSSTS, 2001, FOOD CHEM, V72, P187, DOI 10.1016/S0308-8146(00)00217-X
  • [20] Activation of human neutrophils by the pollutant sodium sulfite:: Effect on cytokine production, chemotaxis, and cell surface expression of cell adhesion molecules
    Ratthé, C
    Pelletier, M
    Roberge, CJ
    Girard, D
    [J]. CLINICAL IMMUNOLOGY, 2002, 105 (02) : 169 - 175